JP2014533727A5 - - Google Patents

Download PDF

Info

Publication number
JP2014533727A5
JP2014533727A5 JP2014543501A JP2014543501A JP2014533727A5 JP 2014533727 A5 JP2014533727 A5 JP 2014533727A5 JP 2014543501 A JP2014543501 A JP 2014543501A JP 2014543501 A JP2014543501 A JP 2014543501A JP 2014533727 A5 JP2014533727 A5 JP 2014533727A5
Authority
JP
Japan
Prior art keywords
cancer
composition
tumor
compound
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014543501A
Other languages
English (en)
Japanese (ja)
Other versions
JP6240083B2 (ja
JP2014533727A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/065236 external-priority patent/WO2013078059A1/en
Publication of JP2014533727A publication Critical patent/JP2014533727A/ja
Publication of JP2014533727A5 publication Critical patent/JP2014533727A5/ja
Application granted granted Critical
Publication of JP6240083B2 publication Critical patent/JP6240083B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014543501A 2011-11-22 2012-11-15 樹状細胞癌ワクチンのための小分子エンハンサー Active JP6240083B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161562497P 2011-11-22 2011-11-22
US61/562,497 2011-11-22
PCT/US2012/065236 WO2013078059A1 (en) 2011-11-22 2012-11-15 Small molecule enhancer for dendritic cell cancer vaccines

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017159116A Division JP2017214420A (ja) 2011-11-22 2017-08-22 樹状細胞癌ワクチンのための小分子エンハンサー

Publications (3)

Publication Number Publication Date
JP2014533727A JP2014533727A (ja) 2014-12-15
JP2014533727A5 true JP2014533727A5 (cg-RX-API-DMAC7.html) 2015-12-24
JP6240083B2 JP6240083B2 (ja) 2017-11-29

Family

ID=48470210

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2014543501A Active JP6240083B2 (ja) 2011-11-22 2012-11-15 樹状細胞癌ワクチンのための小分子エンハンサー
JP2017159116A Pending JP2017214420A (ja) 2011-11-22 2017-08-22 樹状細胞癌ワクチンのための小分子エンハンサー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017159116A Pending JP2017214420A (ja) 2011-11-22 2017-08-22 樹状細胞癌ワクチンのための小分子エンハンサー

Country Status (9)

Country Link
US (3) US9284337B2 (cg-RX-API-DMAC7.html)
EP (2) EP2782994B1 (cg-RX-API-DMAC7.html)
JP (2) JP6240083B2 (cg-RX-API-DMAC7.html)
CN (2) CN106075450A (cg-RX-API-DMAC7.html)
AU (2) AU2012340887A1 (cg-RX-API-DMAC7.html)
CA (1) CA2856379A1 (cg-RX-API-DMAC7.html)
HK (1) HK1201871A1 (cg-RX-API-DMAC7.html)
IL (1) IL232664A0 (cg-RX-API-DMAC7.html)
WO (1) WO2013078059A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9284337B2 (en) * 2011-11-22 2016-03-15 Trustees Of Tufts College Small molecule enhancer for dendritic cell cancer vaccines
WO2016085943A1 (en) 2014-11-25 2016-06-02 Rastelli, Luca Use of ubiquitin-proteasome system inhibitors for treatment of tumors associated with neurofibromatosis type-2
CA2991628C (en) * 2015-07-16 2020-04-07 Bioxcel Therapeutics, Inc. A novel approach for treatment of cancer using immunomodulation
US11000521B2 (en) 2015-08-03 2021-05-11 Institut Pasteur Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy
WO2018049027A1 (en) * 2016-09-07 2018-03-15 Trustees Of Tufts College Combination therapies using immuno-dash inhibitors and pge2 antagonists
US11040027B2 (en) 2017-01-17 2021-06-22 Heparegenix Gmbh Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death
US11559537B2 (en) 2017-04-07 2023-01-24 Trustees Of Tufts College Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists
WO2018187698A2 (en) * 2017-04-07 2018-10-11 Trustees Of Tufts College Combination therapies using caspase-1 dependent anticancer agents and pge2 antagonists
JP2019208422A (ja) * 2018-06-04 2019-12-12 コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー ヒアルロニダーゼを含む新規な組換えエキソソーム及びその用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040145A (en) * 1997-05-07 2000-03-21 Tufts University Potentiation of the immune response
CA2339537A1 (en) * 1998-08-21 2000-03-02 Barbara Wallner Regulation of substrate activity
HK1046846A1 (zh) 1999-05-25 2003-01-30 Point Therapeutics, Inc. 包含boroproline的抗肿瘤复合物
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
CN100392074C (zh) * 2003-10-15 2008-06-04 上海海欣生物技术有限公司 树突状细胞肿瘤疫苗及其制法和用途
CN101247799B (zh) * 2005-07-05 2013-03-27 塔夫茨大学信托人 成纤维细胞活化蛋白α的抑制剂
CN101379069A (zh) * 2005-12-19 2009-03-04 塔夫茨大学信托人 软蛋白酶抑制剂及其前软形式
WO2007123686A2 (en) * 2006-03-31 2007-11-01 Point Therapeutics, Inc. Dpp inhibitors and uses thereof
CA2681351A1 (en) * 2007-03-20 2008-09-25 Trustees Of Tufts College Inhibitors of fibroblast activation protein, and methods of use thereof
EP2154243B1 (en) * 2007-05-17 2016-01-13 ID Pharma Co., Ltd. Method for production of dendritic cell
JP5721441B2 (ja) * 2008-01-31 2015-05-20 キュアバック ゲーエムベーハーCurevac Gmbh 免疫賦活剤/アジュバントとしての式(I)(NuGlXmGnNv)aで表される核酸分子及びその誘導体
US9284337B2 (en) * 2011-11-22 2016-03-15 Trustees Of Tufts College Small molecule enhancer for dendritic cell cancer vaccines

Similar Documents

Publication Publication Date Title
JP2017214420A5 (cg-RX-API-DMAC7.html)
JP2020536091A5 (cg-RX-API-DMAC7.html)
JP7355758B2 (ja) ケモカイン受容体調節剤及びその使用
JP2017536344A5 (cg-RX-API-DMAC7.html)
JP2018504379A5 (cg-RX-API-DMAC7.html)
JP2017519753A5 (cg-RX-API-DMAC7.html)
JP5450381B2 (ja) 化合物、そのような化合物を含有する組成物、及びそのような化合物を用いるがん及び自己免疫疾患の治療法
JP2019512478A5 (cg-RX-API-DMAC7.html)
JP2018507197A5 (cg-RX-API-DMAC7.html)
JP2014503567A5 (cg-RX-API-DMAC7.html)
JP2019513734A5 (cg-RX-API-DMAC7.html)
JP2016534059A5 (cg-RX-API-DMAC7.html)
JP2016053042A5 (cg-RX-API-DMAC7.html)
JP2018504378A5 (cg-RX-API-DMAC7.html)
JP6240083B2 (ja) 樹状細胞癌ワクチンのための小分子エンハンサー
JP2020525429A5 (cg-RX-API-DMAC7.html)
JP2016519062A5 (cg-RX-API-DMAC7.html)
JP2018528261A5 (cg-RX-API-DMAC7.html)
JP2013544846A5 (cg-RX-API-DMAC7.html)
JP2009536191A5 (cg-RX-API-DMAC7.html)
JP2008533191A5 (cg-RX-API-DMAC7.html)
JP2010540556A5 (cg-RX-API-DMAC7.html)
JP2007530595A5 (cg-RX-API-DMAC7.html)
JP2013538213A5 (cg-RX-API-DMAC7.html)
JP2008508287A5 (cg-RX-API-DMAC7.html)